FORMULAÇÃO DE COMPRIMIDO ORAL QUE CONSISTE NUMA COMBINAÇÃO FIXA DE ROSUVASTATINA E EZETIMIBA PARA O TRATAMENTO DE HIPERLIPIDEMIA E DOENÇAS CARDIOVASCULARES
The present invention is an orally consumed fixed combination formulation of both rosuvastatin and ezetimibe in one tablet that is expected to have the same Area Under Curve as two active ingredients taken together individually orally, and pharmaceutically acceptable additives suitable for the preparation. In preferred embodiments of this invention, the rosuvastatin is in the form of rosuvastatin calcium and the pharmaceutically acceptable additives are selected from diluents, disintegrants, glidants, lubricants, colorants and combinations thereof.
